UPM Biomedicals enters into distribution agreement with Brinter for GrowInk bioinks

(UPM, Helsinki, 21 December 2023 at 09:00 EET) – UPM Biomedicals, the forerunner in producing high quality nanofibrillar cellulose for life science and clinical applications, has signed an extensive distribution agreement for GrowInk™  bioinks with Brinter Inc, a Finnish-US medtech/biotech company focusing on the development of cartilage implants using their patented 3D bioprinting technology. The agreement grants Brinter Inc the distribution rights of GrowInk bioinks in United States, Canada, Mexico, Finland, Austria,